Mechanistic insight into the role of microbial dysbiosis in chronic lung allograft dysfunction
Long term survival of lung transplant is lowest among all solid organ transplants and survival is limited due to occurrence of chronic lung allograft rejections (CLAD) or chronic rejections
This talk provides a mechanistic insight into the role of microbial dysbiosis in chronic lung allograft dysfunction, whilst reviewing three recent studies.
- Review pulmonary microbiome and lung transplant
- Gain knowledge on the role of microbial dysbiosis in chronic lung allograft dysfunction
- Gain insights to cases of clinical group for clinical reference
Dr Nirmal S Sharma is the Medical Director of the Lung Transplantation Program at Brigham and Women’s Hospital and VA Boston Medical Center. He is an assistant professor of medicine at Harvard Medical School.
Dr Sharma’s clinical and research interests are in lung transplantation and extracorporeal life support technologies.
Learn more about Dr Nirmal S Sharma, his clinical interests and education here.
Would you like to know more?
Please get in touch with our team who will be able to assist you.